Table 2.
Haemodynamic consequences of using citric instead of acetic acid in dialysis fluids.
| Acetate (A) | Citrate (C) | Citrate (C+) | MD (AC) | MD (AC+) | P(Avs.C) | P(Avs.C+) | |
|---|---|---|---|---|---|---|---|
| Systolic BP (mmHg) | 132.8 ± 15.5 | 128.5 ± 14.1 | 130.7 ± 20.2 | 4.3 | 2.1 | < 0.01 | ns |
| Diastolic BP(mmHg) | 69.5 ± 9.8 | 67.9 ± 9.1 | 68.7 ± 11.6 | 1.6 | 0.8 | < 0.05 | ns |
| Heart rate (beat/min) | 67.6 ± 10.8 | 67.8 ± 12.3 | 68.3 ± 12.5 | -0.2 | -0.7 | ns | ns |
| Blood volume (%) | 96.3 ± 2.8 | 96.6 ± 2.9 | 95.6 ± 3.1 | -0.3 | 0.7 | ns | ns |
| Stroke volume (ml) | 56.6 ± 16.1 | 61.5 ± 14.8 | 63.5 ± 13.1 | -5.0 | -6.9 | ns | ns |
| Peripheral resistence (dyne.sec.cm-5) | 1633 ± 524 | 1581 ± 410 | 1407 ± 235 | 51 | 226 | < 0.001 | < 0.001 |
Blood pressure (BP) and pulse-wave analysis results based on the area under the curve using acetate dialysate (A) vs. citrate dialysate with (C+) or without (C) calcium supplementation.
ns, non significant, MD: mean difference